![A. Injection of different doses of regular insulin (10, 20, 30, and 40... | Download Scientific Diagram A. Injection of different doses of regular insulin (10, 20, 30, and 40... | Download Scientific Diagram](https://www.researchgate.net/profile/Jorge-Bondia/publication/40834719/figure/fig2/AS:601661651312670@1520458724536/A-Injection-of-different-doses-of-regular-insulin-10-20-30-and-40-IU-and-a-40-IU.png)
A. Injection of different doses of regular insulin (10, 20, 30, and 40... | Download Scientific Diagram
![A) Injection of different doses of short-acting (regular) insulin (10,... | Download Scientific Diagram A) Injection of different doses of short-acting (regular) insulin (10,... | Download Scientific Diagram](https://www.researchgate.net/profile/Jorge-Bondia/publication/38063164/figure/fig7/AS:667677152534537@1536198046514/A-Injection-of-different-doses-of-short-acting-regular-insulin-10-20-30-and-40.png)
A) Injection of different doses of short-acting (regular) insulin (10,... | Download Scientific Diagram
![Short-acting insulin analogues versus regular human insulin on postprandial glucose and hypoglycemia in type 1 diabetes mellitus: a systematic review and meta-analysis | Diabetology & Metabolic Syndrome | Full Text Short-acting insulin analogues versus regular human insulin on postprandial glucose and hypoglycemia in type 1 diabetes mellitus: a systematic review and meta-analysis | Diabetology & Metabolic Syndrome | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13098-018-0397-3/MediaObjects/13098_2018_397_Fig1_HTML.png)
Short-acting insulin analogues versus regular human insulin on postprandial glucose and hypoglycemia in type 1 diabetes mellitus: a systematic review and meta-analysis | Diabetology & Metabolic Syndrome | Full Text
![Efficacy, safety and cost-effectiveness comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go wearable insulin delivery device in type 2 diabetes | BMJ Open Diabetes Research & Efficacy, safety and cost-effectiveness comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go wearable insulin delivery device in type 2 diabetes | BMJ Open Diabetes Research &](https://drc.bmj.com/content/bmjdrc/8/2/e001832/F1.large.jpg?width=800&height=600&carousel=1)